September 30, 2014 — Acist Medical Systems Inc., a Bracco Group company, showcased the HDi high-definition intravascular ultrasound system (HD-IVUS) in two live cases at the recent 2014 Transcatheter Cardiovascular Therapeutics (TCT) meeting in September.
The cases were presented from Medstar Washington Hospital Center in D.C. and New York-Presbyterian Hospital/Columbia University Medical Center. The HDi features an intuitive touch screen with 60 MHz image quality, high-speed pullback, a deliverable Kodama HD-IVUS catheter and the Acist HDi console.
The Acist Medical Systems portfolio has recently expanded beyond the CVi contrast delivery system, to include RXi (rapid-exchange fractional flow reserve [FFR]) and HDi technologies.
“Improving patient outcomes by offering cardiologists innovative and improved tools is critical to our business,” said Tom Morizio, president and chief operating officer, Acist Medical Systems. “Our new HD-IVUS is a highly anticipated technology that offers improvements in an area that has lacked innovation for many years. Physicians tell us they appreciate that Acist is raising the bar for IVUS performance.”
The HDi system is easier to use and offers detailed insight that physicians can use to optimize treatment choice for their patients. The HDi provides improved image quality over traditional IVUS systems. During one of the live broadcasts from Columbia Medical Center, Akiko Maehara, M.D., noted, “The ability to visualize plaque morphologies and intravascular structures in high definition is a welcome advancement in imaging.”
Additionally, the intuitive touch-screen display features 60 MHz image quality, which enables easier identification and interpretation of intravascular structures and disease. The Kodama HD-IVUS catheter is deliverable and offers high-speed pullback that is 20 times faster than currently available IVUS systems, lowering the risk of catheter-induced ischemia by reducing pullback time from minutes to seconds.
“We believe it’s our job to provide ongoing innovations for coronary cath labs that improve accuracy, speed, efficiency and delivery,” said Robert Wilson, M.D., founder of Acist Medical Systems. “To continually and dramatically improve technology that improves interventional cardiovascular medicine is our greatest commitment.”
For more information: www.acist.com
November 07, 2024 
